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Abstract: Enamel matrix derivative (EMD) has been found to induce reactive dentin 
formation; however the molecular mechanisms involved are unclear. The effect of EMD 
(5–50 μg/mL) on primary human pulp cells were compared to untreated cells and cells 
incubated with 10−8 M dexamethasone (DEX) for 1, 2, 3, 7, and 14 days in culture. 
Expression analysis using Affymetrix microchips demonstrated that 10 μg/mL EMD 
regulated several hundred genes and stimulated the gene expression of proteins involved in 
mesenchymal proliferation and differentiation. Both EMD and DEX enhanced the 
expression of amelogenin (amel), and the dentinogenic markers dentin sialophosphoprotein 
(DSSP) and dentin matrix acidic phosphoprotein 1 (DMP1), as well as the osteogenic 
markers osteocalcin (OC, BGLAP) and collagen type 1 (COL1A1). Whereas, only EMD 
had effect on alkaline phosphatase (ALP) mRNA expression, the stimulatory effect were 
verified by enhanced secretion of OC and COL1A from EMD treated cells, and increased 
ALP activity in cell culture medium after EMD treatment. Increased levels of interleukin-6 
(IL-6), interleukin-8 (IL-8), and monocyte chemoattractant proteins (MCP-1) in the cell 
culture medium were also found. Consequently, the suggested effect of EMD is to promote 
differentiation of pulp cells and increases the potential for pulpal mineralization to favor 
reactive dentine formation. 
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1. Introduction 
Dental pulp cells have the potential to differentiate into odontoblasts that forms dentin both during 
odontogenesis and reparative/reactive dentin after completion of root formation. [1]. Deposition of 
protective reactive dentin by the induction of hard-tissue deposition is essential to maintain pulpal 
health and prevent hypersensitivity or necrosis after injury or conservative therapy. This effect is 
currently obtained by applications of calcium hydroxide in endodontic and dental traumatology [2]. 
Epithelium derived tooth enamel proteins induce mesenchymal cell differentiation and commercial 
preparations of porcine fetal enamel matrix derivative (EMD) is used clinically for regeneration of 
periodontal defects, which includes new cementum formation, new alveolar bone formation, and new 
periodontal ligament regeneration [3,4]. EMD is reported to stimulate a process mimicking normal 
odontogenesis where epithelial derived and mesenchymal tissue reciprocally interact [5], and can 
thereby serve as a biologically active pulp-dressing agent that specifically induces pulpal wound 
healing and hard-tissue formation without negatively affecting the healthy pulp [6,7]. During dentin 
formation, odontoblasts synthesize both collagen and several non-collagenous proteins like dentin 
sialophosphoprotein (DSSP) and secrete these into the dentin extracellular matrix with subsequent 
matrix mineralization and crystal growth [8]. Previous studies have shown that both pulpal stem cells 
from late and early developmental stages are able to differentiate toward cells of the osteo-/odontoblastic 
lineage, induce alkaline-phosphatase-activity and produce calcified matrix, however this ability was 
gradually lost during culturing [9]. 
Dexamethasone (DEX) is found to induce formation of odontoblast-like cells from cultured human 
dental pulp cells on dentin in vitro and is currently an established method used to stimulate 
differentiation to odontoblast-like phenotype in pulp cell cultures [10]. 
A recent study on human adult dental pulp showed that a stem cell niche with differentiation 
potential might exist in the dental pulp primary cell culture, and that their phenotypes may be altered 
towards osteoblast- or odontoblast-like cells. The dentinogenic markers had peak levels of expression 
around passage 5 and were limited to early passages before 8–9, whereas osteoblastic markers were 
found in all passages [11]. 
Clinical trials have shown that partially pulpotomized EMD gel-treated teeth had significantly less 
tooth hypersensitivity compared to Ca(OH)2-treated [12] with a positive effect on wound healing/new 
tissue and hard tissue formation [13]. 
The mechanism by which EMD influences odontoblastic/osteoblastic differentiation is not well 
understood. A previous report suggests that EMD may directly stimulate odontoblasts or pulp cells to 
produce collagen matrix for calcification [14]. It was also hypothesized that the presence of 
transforming growth factor (TGF) -β1 or amelogenin peptides in EMD may induce cell signaling that 
stimulates matrix formation and mineralization [15]. Bone morphogenetic protein 2 and 4 (BMP 2/4) 
have been reported to contribute to the induction of biomineralization and this effect were reduced by 
noggin, an antagonist of BMP [16], and BMP-expressing macrophages induced by EMD might play 
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important roles in reparative dentin formation [17]. Recent studies suggest that combination of capping 
materials with EMD would increase the quality of capping by increasing biocompatibility of capping 
materials like Ca(OH)2 to induce pulpal healing parallel with calcification [18]. A previous in vivo 
study has shown that the enamel protein ameloblastin significantly increased intrapulpal calcification 
compared to Ca(OH)2 and was suggested to be the biologically active agent in EMD-induced 
reparative dentin formation [19]. Dentin mineralization occurs when calcium is transported from  
the circulation by transmembraneous transport in the odontoblasts alongside non-collagenous 
macromolecules [20]. Dentin sialophosphoprotein (DSSP) is important in biomineralization and 
expression has been demonstrated in both hard and soft tissues, like bone and the pericytes of blood 
vessels in the dental pulp [21]. Other non-collagenous macromolecules important for mineralization of 
dentin and bone are dentin matrix proteins (DMP1s) and recent studies indicate that different forms of 
DMP1 may work collectively in controlling the mineralization process regarding nucleation and 
crystal growth [22]. 
The aim of the present study was to identify possible molecular mechanisms related to EMD’s 
effect on dentin formation and wound healing using primary human pulp cells and odontoblasts  
in vitro. Affymetrix microchip analysis and Real Time quantitative Reverse Transcription PCR  
(qRT-PCR) were performed to analyze changes in gene regulation by EMD whereas changes in 
protein secretion from human pulp cells and odontoblasts was identified using Luminex. 
2. Results 
2.1. Affymetrix Microarray Expression Analysis 
EMD treatment had effect on more than 533 genes measured by microarray analysis. Several major 
cellular pathways were calculated by up- and down-regulation of mRNA expression relative to 
untreated control and exponential effects of gene expressions as log ratio in Table 1. 
Positive effects were found on molecules regulating anti-apoptosis concomitant with down-regulation 
of molecules that stimulates apoptosis and phagocytosis indicating decreased programmed cell death 
(PCD) and atrophy. 
Ankylosis inorganic pyrophosphate transport regulator (ANKH) regulating transport and tissue 
calcification was up-regulated (p = 0.008). 
Up-regulation of genes involved in cell adhesion; contactin associated protein-like 5 (CNTNAP5)  
(p = 0.0002) and neurofascin (NFASC) (p = 0.0005) were found, as well as effect on cell cycle like 
GTP binding by stimulation of septin 1 (SEPT1) (p = 0.003). Effect on chemokine activity was 
confirmed by up-regulation of interleukin 8 (IL-8) (p = 0.0002) and IL-11 (p = 0.0002). 
Growth factors; bone morphogenetic protein 4 (BMP4) (p = 0.027), osteoglycin (OGN) (p = 0.095), 
platelet derived growth factor D (PDGFD) (p = 0.0002) and fibroblast growth factor 7 (FGF7)  
(p = 0.0002) were down-regulated, whereas transcription factor binding to immunoglobulin heavy 
constant mu (IGHM) enhancer 3 (TFE3) (p = 0.03) was enhanced by EMD treatment. TFE3 is 
involved in the TGF beta signaling pathway and promotes TGF beta effects and aberrant TFE3 
transcription activity is involved in the pathogenesis of alveolar soft-part sarcoma (ASPS) [23]. 
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Transcription factors important to neural development and post-traumatic healing were up-regulated 
including General transcription factor IIIA (GTF3) (p = 0.046) involved in neurogenesis [24] and 
Forkhead box protein G1 (FOXG1B) (p = 0.038) linked to development of hippocampal dentate gyrus 
and CNS structures [25]. This is relevant as the dental pulp is a sensory organ. 
Factors stimulating microtubule cytoskeleton including microtubule-based movement, protein 
transport, vesicle-mediated transport, cell mitosis, and proliferation were up-regulated by EMD  
treatment (Table 1). 
Topmost regulated molecules after Affymetrix expression analysis were identified by Ingenuity 
Pathway Analysis (IPA) (Ingenuity Systems) as high mobility group AT-hook 2 (HMGA2)  
(p = 0.0015), C-type lectin domain family 16, member A (CLEC16A) (p = 0.001), transmembrane 
protease, serine 7 (TMPRSS7) (p = 0.0009), grainyhead-like 1 (GRHL1) (p = 0.0007), slingshot 
protein phosphatase 2 (SSH2) (p = 0.0005), contactin associated protein-like 5 (CNTNAP5)  
(p = 0.0002), chromosome 10 open reading frame 140 (C10ORF140) (p = 0.002), Fanconi anemia, 
complementation group B (FANCB) (p = 0.000005), neurofascin (NFASC) (p = 0.0005), dedicator of 
cytokinesis 5 (DOCK5) (p = 0.0005) (Table 1). 
2.2. Gene Expression Analyzed by Real-Time PCR 
In cells treated with EMD (10 μg/mL) the gene expression of DSPP initially decreased after three 
and seven days of incubation (p = 0.002 and p ≤ 0.001, respectively) followed by a significant  
(p ≤ 0.001) 11-fold increase at day 14. DMP-1 expression was upregulated by 2-fold increase at all 
time points after 10 μg/mL EMD treatment (p ≤ 0.001, p ≤ 0.001, and p ≤ 0.001, respectively)  
(Figure 1A, left panel). An increase in odontoblast specific genes and differentiation towards 
odontoblasts, were confirmed by a similar increase in DSPP and DMP-1 expression in cells treated 
with DEX (Figure 1B, right panel). 
EMD (10 μg/mL) induced reduced expression of alkaline phosphatase (ALP) at day three and seven 
(p ≤ 0.001 and p ≤ 0.001, respectively), and significant 31-fold enhancement (p ≤ 0.001) at day 14 
(Figure 1C, left panel) compared to untreated control. After three days incubation with 10 μg/mL 
EMD the OC gene expression was 11-fold higher (p ≤ 0.001), and COL1A1 expression was 5-fold 
higher (p ≤ 0.001) compared to the expression in untreated pulp cells. Both OC and COL1A1 
expression were reduced after EMD treatment for 7 and 14 days (p ≤ 0.001 and p ≤ 0.001, 
respectively) (Figure 1C, left panel). In cells treated with DEX both OC (p ≤ 0.001) and COL1A1  
(p ≤ 0.001) expression was doubled after three days incubation, whereas after 14 days of DEX 
treatment OC expression was enhanced 22-fold (p ≤ 0.001) and COL1A1 1200-fold (p ≤ 0.001)  
(Figure 1D, right panel) compared to untreated cells. No effect on runt-related transcription factor 2 
(RUNX2) expression was found after three days, but RUNX2 were reduced after 7 and 14 days  
(p ≤ 0.001 and p = 0.003, respectively) treatment with EMD (Figure 1D, right panel). DEX doubled 
the RUNX2 expression after seven days (p ≤ 0.001) and induced a 96-fold increase after 14 days  
(p ≤ 0.001) of incubation (Figure 1D, right panel). 
EMD reduced the expression of AMEL at day 3 and 7 (p = 0.047 and p ≤ 0.001, respectively) and 
enhanced the expression more than 21-fold (p ≤ 0.001) at day 14 compared to control, whereas the 
AMBN expression were reduced (p ≤ 0.001 for all) at all time points tested (Figure 1E, left panel). The 
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equivalent effects were found in pulp cells after DEX treatment (Figure 1F, right panel) confirming 
that EMD induced an expression profile of enamel proteins similar to an odontoblastic phenotype. 
Table 1. Topmost regulated molecules after Affymetrix expression analysis (log ratio). 
Biological 
Response 
Probe Set Identification 
(Affymetrix) 
Signal Log 
Ratio 
Gene 
Symbol 
Gene Title 
Apoptosis 
204614_at 1, 8 SERPINB2
serine (or cysteine) proteinase inhibitor, clade B 
(ovalbumin) 
204467_sat −1 SNCA synuclein, alpha (non A4 component of  
amyloid precursor) 
205681_at 1, 5 BCL2A1 BCL2-related protein A1 
202095_s_at 1, 4 BIRC5 baculoviral IAP repeat-containing 5 (survivin) 
204237_at −1 GULP1 GULP, engulfment adaptor PTB domain 
containing 1 
Cell adhesion 
205679_x_at −1, 2 AGC1 aggrecan 1 (chondroitin sulfate proteoglycan 1) 
1553418_aat 3, 8 CNTNAP5 contactin associated protein-like 5 
222853_at −1, 1 FLRT3 fibronectin leucine rich transmembrane protein 3
243645_at 3, 5 NFASC neurofascin 
205908_s_at −1, 5 OMD osteomodulin 
204649_at 1, 2 TROAP trophinin associated protein (tastin) 
238871_at −1, 7 MLLT4 Myeloid/lymphoid or mixed-lineage leukemia 
242472_x_at −3, 7 FNBP4 Formin binding protein 4 
231726_at −1 PCDHB14 protocadherin beta 14 
214111_at 1, 1 OPCML 
opioid binding protein/cell adhesion  
molecule-like 
Cell cycle 
227552_at 1, 8 sep.01 septin 1 
204456_s_at −1 GAS1 growth arrest-specific 1 
204991_s_at 1 NF2 neurofibromin 2 (bilateral acoustic neuroma) 
211094_s_at −1, 8 NF1 neurofibromin 1 (neurofibromatosis) 
225123_at −1, 1 SESN3 Sestrin 3 
202859_x_at 1, 9 IL8 interleukin 8 
Growth factor 
222722_at −1, 4 OGN osteoglycin (osteoinductive factor, mimecan) 
219304_s_at −1, 5 PDGFD platelet derived growth factor D 
205782_at −1, 1 FGF7 fibroblast growth factor 7  
(keratinocyte growth factor) 
211518_s_at −1, 3 BMP4 bone morphogenetic protein 4 
Transcription 
1569098_sat −1, 2 TP53BP1 tumor protein p53 binding protein, 1 
203359_s_at 1, 1 MYCBP c-myc binding protein 
201417_at −1 SOX4 SRY (sex determining region Y)-box 4 
227162_at −1, 1 ZBTB26 zinc finger and BTB domain containing 26 
1568873_at 1, 2 ZNF519 zinc finger protein 519 
221530_s_at −1, 2 BHLHB3 basic helix-loop-helix domain containing,  
class B, 3 
204915_s_at 1 SOX11 SRY (sex determining region Y)-box 11 
206018_at 1, 4 FOXG1B forkhead box G1B 
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Table 1. Cont. 
Biological 
Response 
Probe Set Identification 
(Affymetrix) 
Signal Log 
Ratio 
Gene 
Symbol 
Gene Title 
microtubule 
cytoskeleton 
202890_at −1 MAP7 microtubule-associated protein 7 
206364_at 1 KIF14 kinesin family member 14 
221258_sat 1, 4 KIF18A kinesin family member 18A 
219570_at −1 C20orf23 chromosome 20 open reading frame 23 
219306_at 1, 1 KIF15 kinesin family member 15 
209408_at 1, 2 KIF2C kinesin family member 2C 
218755_at 1, 1 KIF20A kinesin family member 20A 
210052_sat 1, 2 TPX2 
TPX2, microtubule-associated protein homolog 
(Xenopus laevis) 
219588_sat 1, 1 MTB more than blood homolog 
204162_at 1, 2 KNTC2 kinetochore associated 2 
209680_sat 3, 1 KIFC1 kinesin family member C1 
38158_at 1, 4 ESPL1 extra spindle poles like 1 (S. cerevisiae) 
218009_sat 1, 3 PRC1 protein regulator of cytokinesis 1 
2047at 1, 4 KIF23 kinesin family member 23 
225540_at −1, 8 MAP2 Microtubule-associated protein 2 
2.3. Proteins in Culture Medium Measured by Elisa and Luminex 
After one-day incubation 50 µg/mL EMD induced a 1.4-fold increase in the ALP activity (ALP/TP)  
(p = 0.04) in the cell culture medium (Figure 2A). No significant effects were observed at other time 
points by any of the EMD concentrations tested (Figure 2A). 
EMD treatments (5, 10, and 50 µg/mL) induced an up to 2.5-fold increase in OC secretion  
(p = 0.017, p < 0.001, and p < 0.001, respectively) at day one, a 1.8-fold at day two (p = 0.009,  
p ≤ 0.001, and p ≤ 0.001, respectively) and a 2.2-fold at day three (p ≤ 0.001, p ≤ 0.001, and p ≤ 0.001, 
respectively) compared to control (Figure 2B). 
COL1A levels in the medium were enhanced by EMD (5, 10, 50 µg/mL); up to 3.5-fold at day one  
(p ≤ 0.001, p = 0.010, and p ≤ 0.001, respectively), and 2.5-fold at day two (p = 0.030, p ≤ 0.001, and  
p = 0.009, respectively) compared to control. No significant changes were found at day three  
(Figure 2C). No effect of EMD was found on OC and collagen type 1 secretion from pulp cells after 7 
and 14 days of incubation (data not shown). 
EMD (5, 10, 50 µg/mL) induced a 3-fold increase in IL-6 secretion to the medium after one day  
(p = 0.042, p = 0.037, and p = 0.041, respectively) and two days (p ≤ 0.001, and p ≤ 0.001, 
respectively) (Figure 3A). 
Whereas IL-8 secretion was increased 7-fold after one day (10 and 50 µg/mL EMD; p = 0.023 and  
p = 0.013, respectively), 10-fold after two days (5, 10, and 50 µg/mL; p = 0.028, p = 0.034, and  
p = 0.006, respectively), 9-fold after three days (p = 0.002, p = 0.003, and p ≤ 0.001, respectively) 
compared to control (Figure 3B). 
The secretion of MCP-1 was enhanced 3-fold after one day (10 and 50 µg/mL; p = 0.035 and p = 0.004, 
respectively), 2-fold after two days (5, 10, and 50 µg/mL; p = 0.022, p = 0.014, and p = 0.002, 
respectively), 3-fold after three days (5 and 50 µg/mL; p = 0.009 and p = 0.001, respectively) (Figure 3C). 
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Figure 1. Effect of Enamel matrix derivative (EMD) (10 μg/mL) on mRNA expression of 
dentin sialophosphoprotein (DSSP) and dentin matrix acidic phosphoprotein 1 (DMP-1) 
(A) (left panel) and dexamethasone (DEX) (10−8 M) (B) (right panel), osteocalcin (OC), 
alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2) and collagen  
type 1 (COL1A1) (C) (left panel) and DEX (10−8 M) (D) (right panel); and amelogenin 
(AMEL) and ameloblastin (AMBN) (E) (left panel) and DEX (10−8 M) (F) (right panel) in 
primary human pulp cells. The data is presented as mean ± SD and calculated in 
percentage of untreated cells (100%) at each time point. 
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Figure 2. Effect of EMD (5, 10, 50 μg/mL) on the alkaline phosphatase (ALP) activity (A); 
osteocalcin (OC) (B); and collagen type 1 (COL1A1) secretion (C) in the cell medium by 
primary human pulp cells. The data is presented as mean ± SD in percent of untreated cells 
(100%) at each timepoint. 
 
 
 
  
A
B
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days
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Figure 3. The effect of 5, 10, 50 μg/mL of EMD on the concentration of IL-6 (A); IL-8 (B); 
and MCP-1 (C) in the cell culture medium. The data are presented as mean ± SD and 
calculated in percent of untreated cells (100%) at each time point. 
 
 
 
2.4. No Cytotoxic Effects Was Discovered 
There were no changes in the Lactate dehydrogenase (LDH) activity in the cell culture medium 
after EMD treatment of the primary pulp cells (data not shown) at any of the time points tested, 
indicating that EMD at the concentrations used here had no major cytotoxic effects on the primary 
human pulp cells. 
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3. Discussion 
3.1. Affymetrix Analysis Showed Effect on Transcription Factors and DNA Repair 
Affymetrix microarray expression analysis has previously shown that EMD activate the expression 
of a high number of genes in the primary human osteoblasts [26], and we found the similar pattern in 
pulp cells. RUNX2, a transcriptional factor regulating, e.g., OC, was not altered, whereas v-maf avian 
musculoaponeurotic fibrosarcoma oncogene homolog (MAF) was down-regulated. MAF and RUNX2 
are cooperating in differentiation of osteoblasts in favor of adipocytes however this differentiation 
switch is still unclear [27]. Expression of FANCB, a gene encoding proteins involved in protection and 
repair of DNA damage [28], was increased. 
3.2. EMD Had Positive Effect on Genes Involved in both Neural and Mesenchymal Healing 
HMGA2 were highly expressed in pulp cells 24 h after EMD treatment. This is a gene that is a 
transcriptional regulating factor that induces differentiation into certain mesenchymal cell lineages [29] and 
is suggested to have stimulating effect on bone mineral density (BMD) and osteogenesis [30]. 
An in vitro study on gene profile in periodontal ligament cells (PDL) demonstrated positive effect 
of EMD on genes involved in protein synthesis and mineralization ability [31]. This confirms similar 
effect of EMD on PDL and pulp cells, both tissues that mainly consists of fibroblasts and cells capable 
of mineralization. 
ANKH regulates intracellular and extracellular levels of pyrophosphate/inorganic phosphate critical 
for maintaining mineral homeostasis and dysfunction of ANKH gene is linked to Craniometaphysial 
dysplasia (CMD) [32]. Increased ANKH expression indicates that EMD increases the levels of 
pyrophosphate/inorganic phosphate, thus, facilitating mineralization. 
Evolutionary it is significant that pulp is a part of the sensory dental organ. During odontogenesis 
reciprocal stimulation and effect between ecto-mesenchymal tissue and neural tissue is crucial for 
development of the dental pulp. After pulp injury regulation of innervation and inflammation is 
important to preserve pulpal health trough both regulation of re-innervation and intrapulpal tissue 
pressure. Significant markers for neural development up-regulated in pulp cells after EMD treatment 
were CLEC16A [33] with effect on activation and control of neuroinflammation, CNTNAP5 involved 
in CNS development [34] and NFASC that regulate neural development and axon innervations [35]. 
The Affymetrix analysis indicates that EMD have positive effects on genes that regulates hard 
tissue mineralization and facilitates innervations of the pulp. These findings support clinical trials 
finding that EMD induces less postoperative pain and tooth hypersensitivity [12] and increases 
reparative/ tertiary dentin formation and intrapulpal mineralization [13]. 
3.3. EMD Induces Both Expression and Secretion of Osteogenic Proteins and Increased 
Mineralization Potential 
Both qRT-PCR and Enzyme-linked immunosorbent assay (ELISA) demonstrated positive effect on 
pulp cells with enhanced gene up-regulation and secretion of OC and COL1A and increased ALP 
activity after EMD treatment. EMD has previously been shown to have similar stimulatory effect on 
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osteoblasts [26]. EMD had a dose dependent effect on both expression and secretion of osteogenic 
markers, such as OC and COL1A, and mineralization potential trough increased ALP activity in pulp cells; 
indicating a dose specific effect on osteogenic proteins and increased mineralization in the pulp tissue. 
Gene array of primary human osteoblasts exposed to EMD have in a previous study demonstrated 
that EMD up-regulates several differentiation markers including collagen isoforms among COL1A and 
ALP as well as growth factors like VEGF [36]. Our study indicates a similar effect of EMD on gene 
expression in osteoblasts and in pulp cells. 
Human pulp cells were stimulated by EMD to up-regulate expression of DSSP and DMP-1 similar 
to DEX treatment; an acknowledged method to stimulate transformation of pulpal pluripotential stem 
cells to differentiate to odontoblasts [10]. Primary dental pulp contains approximately two percent 
stem cells able to differentiate to mineralizing cells [37]. In pulp tissue these genes are up- and  
down-regulated during growth and healing leading to both innate dentinogenic potential and 
osteogenic potential. RUNX2 expression was found to be unchanged following EMD treatment. This 
is supported by a previous study that demonstrated no effect of EMD on the mRNA levels of RUNX2, 
but changed the location of expression from the cytoplasm to the nucleus in osteoblasts [38]. The pulp 
cells exhibit differentiation trough expression of genes DSSP, DMP-1, ALP and OC markers for 
mineralizing tissue like bone and dentin [11]. OC and DSSP have previously been found in both 
odontoblasts and mineralizing dentin [39], and DMP-1 has been found to regulate the promoter for both 
DSPP and OC [40]. Our study demonstrated effect on gene expression level on DSPP, DMP-1, ALP, 
and OC after EMD treatment. Thus our findings indicate that EMD has potent positive effect on 
differentiation of pulp cells capable of inducing hard tissue formation. EMD as the product Emdogain® 
has clinically been used to enhance bone healing after destructive marginal periodontitis [41] by 
inducing up-regulation of genes involved mesenchymal proliferation and differentiation favoring bone 
formation over bone resorption [42]. We speculate that EMD has potential for other applications like 
pulp capping or sealing before restorative treatment by stimulating pulpal mineralization and less 
hypersensitivity and postoperative pain. 
3.4. EMD Has Immunoregulatory Effect on Pulp Cells 
EMD had an acute stimulatory effect on the expression (IL-8, IL-11) and secretion (IL-6, IL-8  
and MCP-1) of cytokines that mediates both inflammatory and vascular responses. IL-6 has 
immunomodulating effect and might be both a pro- and anti inflammatory cytokine. Anti-inflammatory 
effect is achieved by regulation of IL-1β and TNF-α, the major inflammatory cytokines, and previous 
studies have found that IL-6 suppress IL-1 (α, β) mRNA in CNS [43] and is essential for TNF-α 
responses like fever [44]. In our study, we found that neither IL-1β nor TNF-α were elevated after 
EMD treatment. No effect on other immunostimulatory cytokines like IL-10, INF-γ and GM-CSF were 
found indicating no pro-inflammatory effect of EMD and is supported by a cDNA microarray study on 
PDL cells that concluded that EMD down-regulates the expression of genes involved in the early 
inflammatory phases of wound healing while simultaneously up-regulating genes encoding growth and 
repair-promoting molecules [45]. 
Previous studies have demonstrated that DMP-1 (10 ng/mL) that is involved in intrapulpal 
mineralization stimulates the production of IL-6 and IL-8 from pulp fibroblasts [46], and we might 
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speculate that increased DMP-1 expression might trigger increased IL-6 and IL-8 secretion. Other 
studies have shown that IL-6 and IL-8 expression have immunomodulatory properties of mesenchymal 
stem cells in periapical lesions [47]. In vivo studies have shown that IL-11 together with IL-6 is 
required for normal bone remodeling [48] and IL-11 supposed to have osteotrophic properties and 
mediates anti-inflammatory responses to major injury [49]. A recent study has shown that IL-11 
inhibits adipogenic differentiation and stimulates osteoblastogenic differentiation from human bone 
marrow mesenchymal stem cells and increases ALP activity [50]. 
MCP-1 was increased after EMD treatment in pulp cells indicating effect on vascularization. MCP-1 
acts as a chemokine to recruit mononuclear cells to the dental follicle and an important vascular 
signaling factor [51]. 
EMD treatment in concentrations used has stimulatory effect on pulp cells in vitro inducing gene 
expression and secretion of factors promoting tissue healing and mineralization. 
4. Experimental Section 
4.1. Cell Culture and Treatment 
Commercially available primary human pulp cells (passage 5) from unerupted intact human third 
molars (DPK-DTPC-H, Dominion Pharmakine, Derio, Spain) were grown in DMEM medium (PAA 
laboratories, Pashing, Austria) containing 10% fetal bovine serum, 50 U/mL penicillin and 50 μg/mL 
streptomycin. The cultures were incubated at 37 °C in a humidified atmosphere of 95% air and  
5% CO2. The medium was changed three times weekly and the cells were sub-cultured and seeded in 
6-well plates in duplicates. EMD was dissolved in 10% acetic acid to a stock solution of 10 mg/mL 
prior to dilution in cell culture medium to final concentration. The cells were incubated with 5, 10, or  
50 μg/mL EMD (Batch 9121, Biora, Malmö, Sweden) was obtained directly from manufacturer Biora 
as freeze-dried protein in tubes. EMD was dissolved directly in cold cell culture medium before it was 
incubated at 37 °C prior to administration. 
In parallel, cells treated with dexamethasone (DEX) (10−8 M) to regulate the commitment to form 
odontoblast-like cells [52], were used as positive control, whereas untreated cells were used as 
negative control. Cells and cell culture medium were harvested after 1, 2, 3, 7, and 14 days. All cell 
culture treatments were performed three individual times. 
4.2. Purification of RNA, Microarray Analysis by Affymetrix 
The effect of EMD on gene expression in primary human pulp cells was studied after 24 h 
incubation with 10 μg/mL EMD and performed three individual times. RNA was isolated using 
TRIZOL reagent (Life Technologies, Gaithersburg, MD, USA) according to manufacturer instructions 
and further purified using the RNeasy kit (Qiagen Inc., Valencia, CA, USA) in order to get rid of 
organic components. 
Double stranded cDNA and biotin labeled cRNA probes were made from 5 μg total RNA using  
the Superscript Choice system (Invitrogen life technologies, Carlsbad, CA, USA) and the Bioarray  
(Enzo Biochem, New York, NY, USA), respectively. Procedures were according to recommendations 
from Affymetrix (Santa Clara, CA, USA). cRNA was hybridized to HG-U133A microchips 
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(Affymetrix) containing cDNA oligonucleotides representing more than 22,000 transcripts, followed 
by washing and staining on the Gene Chips Fluidics Station 450 (Affymetrix) according to 
manufacturer instructions. The chips were scanned on the Affymetrix Gene Array 2500 scanner. The 
quality of the RNA and probe was controlled by an Affymetrix based test measuring the ratio between  
5' and 3' mRNAs for β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and found to 
be satisfactory. The datasets were processed by the Affymetrix Mas5.0 software, and signal values 
representing the expression level of each transcript were generated. 
TATA binding protein (TBP) mRNA was included in the reactions and used as internal standard. 
TBP was verified not to be differentially expressed before and after treatment with parathyroid 
hormone (PTH) from Affymetrix expression analysis. Predesigned primers and a probe labeled with 
the reporter fluorescent dye VIC, specific for TBP, were used. For the Real time rtPCR, cDNA was 
amplified under the following conditions: 50 °C for 2 min, and 94.5 °C for 10 min, followed by  
40 cycles at 97 °C for 30 s and 59.7 °C for 1 min. The relative mRNA amount of each gene was 
calculated using the Comparative CT Method “Separate Tubes” following the instructions; PE Applied 
Biosystems and adjusted for the expression of TBP mRNA. 
4.3. Alkaline Phosphatase (ALP) Activity 
ALP activity was quantified by measuring the hydrolysis of para-Nitrophenylphosphate (pNPP) 
(Sigma Diagnostics, St. Louis, MI, USA) at 405 nm. Standard curves, constructed using calf intestinal 
alkaline phosphatase (CIAP) (Promega, Madison, WI, USA), were run in parallel for quantification 
purposes and performed three individual times. The total protein content in the culture medium was 
determined using Sigma Microprotein PR assay kit with a Protein Standard Solution Calibrator (Sigma 
Diagnostics). Analyses were performed using a Cobas Mira chemistry analyzer (Roche Diagnostics, 
Basel, Switzerland). Intra-assay and inter-assay variability were less than 2.4% and 3.2%, respectively. 
The assay detection range was 10–2000 mg/L. ALP activity was calculated in terms of nmol of 
pNPP/min/mg of total protein in each individual sample. The activity in cell culture medium was 
finally expressed in % of the negative controls at each of the time points. 
4.4. mRNA Isolation Prior to Real Time RT-PCR Quantification 
Cells were lysed in lysis/binding buffer (100 mM Tris-HCl, pH 8.0, 500 mM LiCl, 10 mM EDTA, 
pH 8.0, 0.5 mM dithiothreitol (DTT), and 1% sodium dodecyl sulfate (SDS)). mRNA was isolated 
using magnetic beads (oligo (dT)25) as described by the manufacturer (Dynal AS, Oslo, Norway). 
Beads containing mRNA were resuspended in 10 mM Tris-HCl, pH 8.0, and stored at −70 °C until use.  
1 µg of mRNA was used to synthesize first-strand complementary DNA (cDNA) using RevertAid™ 
First Strand cDNA Synthesis kit (Fermentas, St. Leon Route, Germany). 
4.5. Real-Time PCR Quantification of Target Genes for Dental Biomineralization 
Real-time RT-PCR was performed in a CFX384 (Bio-Rad, Hercules, CA, USA) using the 
SsoAdvanced SYBR Green Green Supermix (Bio-Rad). The thermal profile was as follows: 
denaturing at 98 °C for 5 min followed by 40 cycles with denaturing at 95 °C for 10 s annealing 60 °C 
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for 60 s, primer extension at 72 °C for 30 s. Reactions were performed in triplicates on a 384-well 
plate. The primer sequences for the target genes (runt-related transcription factor 2 (RUNX2), 
osteocalcin (OC), COL1A1, ALP, dentin sialophosphoprotein (DSPP), dentin matrix acidic 
phosphoprotein 1 (DMP1), amelogenin (AMEL), ameloblastin (AMBN)) are listed in Table 2. The 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as reference. The 
efficiency of each set of primers was between 95% and 100%. The real time RT-PCR data was 
analyzed using the ΔCt method, with efficiency (E) correction for the individual transcripts. Where 
relative expression = (Etarget) ΔCttarget(control-sample)/(Eref) ΔCtref(control-sample). 
Table 2. Sequences of real-time PCR (RT-PCR) primers. 
Gene Sequence of Left Primer Sequence of Right Primer 
AMELX 5'-CTCATCACCACATCCCAGTG-3' 5'-TGTTGGATTGGAGTCATGGA-3' 
AMBN 5'-AGAGCACAGTGCATGTCAGC-3' 5'-AAGAACGGCACTGCAAAACT-3' 
DSPP 5'-GGGAAAGTGGTGGTGGTGCT-3' 5'-CACCAGGGCATGGCTGTAAG-3' 
DMP1 5'-AAGCAGACAGCGAATCCAGT-3' 5'-CTGCTGAGCTGCTGTGAGAC-3' 
OC 5'-GCAAGTAGCGCCAATCTAGG-3' 5'-GCTTCACCCTCGAAATGGTA-3' 
ALP 5'-GACAAGAAGCCCTTCACTGC-3' 5'-AGACTGCGCCTGGTAGTTGT-3' 
COL1A1 5'-CATCTCCCCTTCGTTTTTGA-3' 5'-CCAAATCCGATGTTTCTGCT-3' 
RUNX2 5'-TTACTTACACCCCGCCAGTC-3' 5'-CACTCTGGCTTTGGGAAGAG-3' 
GAPDH 5'-CTCTGCTCCTCCTGTTCGAC-3' 5'-ACGACCAAATCCGTTGACTC-3' 
4.6. Analysis of the Cell Culture Medium 
Enzyme-linked immunosorbent assay (ELISA) was used to quantify the release of osteocalcin (OC) 
(BioSource, Camarillo CA, USA) and procollagen I type A (COL1A) (Takara Bio Inc.,  
Ohtsu-shi, Japan) to the cell culture medium collected from primary human pulp cell cultures 
according to manufacturer’s description. Intra-assay and inter-assay variability were less than 2.9% 
and 3.5%, respectively. The assay detection range was 0–65 ng/mL (OC) and 0–640 ng/mL (COL1A). 
OC and COL1A concentrations were calculated relative to the amount of total protein in each sample 
and presented as % untreated cells at the different time points. 
4.7. Cytokine Levels in the Culture Medium 
Multianalyte profiling was performed using the Luminex-100 system and the XY Platform 
(Luminex Corporation, Austin, TX, USA). Calibration microspheres for classification and reporter 
readings as well as sheath fluid were also purchased from Luminex Corporation. The acquired 
fluorescence data were analyzed by the STarStation software (Version 2.0; Applied Cytometry 
Systems, Sheffield, UK). Prior to analysis, the samples were concentrated 10 times using Microsep™ 
Centrifugal tubes with 3 k Dada cut-off from Pall Life Science (Ann Armor, MI, USA). The 
concentrations of different cytokines; granulocyte-macrophage colony-stimulating factor (GM-CSF), 
interferon (IFN-α, IFN-γ), interleukins (IL-1β, IL-Ra, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, 
IL-12p40/p70, IL-13, IL-15, IL-17), interferon gamma-induced protein (IP-10), monocyte chemotactic 
protein-1 (MCP-1), monokine induced by gamma interferon (MIG), macrophage inflammatory 
proteins (MIP-1α, MIP-1β), tumor necrosis factor-alpha (TNF-α), Eotaxin-1 (CCL11), and RANTES 
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(CCL5) in the cell culture medium were determined using the Human Cytokine 20-plex from BioSource 
(Carmarillo, CA, USA). All analyses were performed according to the manufacturers’ protocols. 
4.8. Lactate Dehydrogenase (LDH) Activity 
Cell viability was confirmed by monitoring the release of lactate dehydrogenase (LDH) into the 
medium. LDH was measured using the microplate based Cytotoxicity Detection Kit (LDH) 
(Boehringer, Mannheim, Germany). According to the manufacturer’s protocol, 50 μL aliquots of cell 
culture medium were used and absorbance read on a microplate reader (Asys expert 96, Asys Hitech, 
Eugendorf, Austria) at 450 nm. Analysis were performed on three individual cellular experiments. 
4.9. Statistics 
Statistical evaluation of real-time RT-PCR data was carried out using graphPad Instat (Graphpad 
Sofware Inc., La Jolla, CA, USA), whereas SigmaStat software (Systat Software Inc., San Jose, CA, 
USA) were used for the protein analysis. Protein analysis data passed normality and equal variance 
tests. Statistical comparison between groups and treatments was performed using parametric test  
one-way analysis of variance (one-way ANOVA) and post hoc Holm-Sidak tests. A probability of less 
than or equal to 0.05 was considered significant. Data were presented as a percentage of untreated cells  
(=100%) at each time point of observation. 
5. Conclusions 
EMD have stimulating effects on expression of genes involved in mesenchymal proliferation and 
differentiation in pulp cells measured by Affymetrix microarrays and qRT PCR. This promotive effect 
on factors involved in differentiation, signalling and mineralisation were confirmed on protein level by 
ELISA, Luminex and ALP/TP. This in vitro study indicate some of the molecular mechanisms 
involved in EMD’s stimulatory effect on wound healing in pulp tissue. This is an in vitro study to 
describe potential effect in the dental pulp and adjacent dentin with the limitations of the study design, 
thus, further studies must be done in vivo to confirm effect on dental organ level. 
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